$REGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REGENERON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in REGENERON PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 48 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 606.79 | 353 | 214,197 | 27,711 | 28.1 K to 27.7 K (-1.26 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 605.14 | 289 | 174,885 | 28,064 | 28.4 K to 28.1 K (-1.02 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 604.14 | 50 | 30,207 | 28,353 | 28.4 K to 28.4 K (-0.18 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 603.68 | 131 | 79,082 | 28,403 | 28.5 K to 28.4 K (-0.46 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 602.38 | 110 | 66,262 | 28,534 | 28.6 K to 28.5 K (-0.38 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 592.43 | 1,086 | 643,379 | 28,644 | 29.7 K to 28.6 K (-3.65 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 1,500 | 409,050 | 29,730 | 28.2 K to 29.7 K (+5.31 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 592.43 | 1,630 | 965,661 | 28,230 | 29.9 K to 28.2 K (-5.46 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 2,250 | 613,575 | 29,860 | 27.6 K to 29.9 K (+8.15 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 592.43 | 1,630 | 965,661 | 27,610 | 29.2 K to 27.6 K (-5.57 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 2,250 | 613,575 | 29,240 | 27 K to 29.2 K (+8.34 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 592.40 | 1,811 | 1,072,836 | 26,990 | 28.8 K to 27 K (-6.29 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 2,500 | 681,750 | 28,801 | 26.3 K to 28.8 K (+9.51 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 592.43 | 2,536 | 1,502,402 | 26,301 | 28.8 K to 26.3 K (-8.79 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 3,500 | 954,450 | 28,837 | 25.3 K to 28.8 K (+13.81 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 592.43 | 2,536 | 1,502,402 | 25,337 | 27.9 K to 25.3 K (-9.10 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 3,500 | 954,450 | 27,873 | 24.4 K to 27.9 K (+14.36 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 607.20 | 2 | 1,214 | 28,743 | 28.7 K to 28.7 K (-0.01 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 606.50 | 15 | 9,098 | 28,745 | 28.8 K to 28.7 K (-0.05 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 605.40 | 9 | 5,449 | 28,760 | 28.8 K to 28.8 K (-0.03 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 604.51 | 21 | 12,695 | 28,769 | 28.8 K to 28.8 K (-0.07 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 603.64 | 11 | 6,640 | 28,790 | 28.8 K to 28.8 K (-0.04 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 602.48 | 10 | 6,025 | 28,801 | 28.8 K to 28.8 K (-0.03 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 601.56 | 10 | 6,016 | 28,811 | 28.8 K to 28.8 K (-0.03 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 600.53 | 2 | 1,201 | 28,821 | 28.8 K to 28.8 K (-0.01 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 599.59 | 15 | 8,994 | 28,823 | 28.8 K to 28.8 K (-0.05 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 598.58 | 5 | 2,993 | 28,838 | 28.8 K to 28.8 K (-0.02 %) |
Jun 01 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 595.00 | 500 | 297,500 | 7,700 | 8.2 K to 7.7 K (-6.10 %) |
Jun 01 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 578.00 | 500 | 289,000 | 8,200 | 8.7 K to 8.2 K (-5.75 %) |
Jun 01 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 598.02 | 500 | 299,010 | 2,400 | 2.9 K to 2.4 K (-17.24 %) |
Jun 01 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 580.00 | 500 | 290,000 | 2,900 | 3.4 K to 2.9 K (-14.71 %) |
Jun 01 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 578.94 | 1,000 | 578,940 | 6,643 | 7.6 K to 6.6 K (-13.08 %) |
May 29 2020 | REGN | REGENERON PHARMACE ... | Sanofi | Sell | S | 509.85 | 2,399,552 | 1,223,411,587 | 400,000 | 2.8 M to 400 K (-85.71 %) | |
May 29 2020 | REGN | REGENERON PHARMACE ... | Sanofi | Sell | S | 509.85 | 20,421,899 | 10,412,105,205 | 0 | 20.4 M to 0 (-100.00 %) | |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 30.63 | 77,309 | 2,367,975 | 0 | |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 30.63 | 77,309 | 2,367,975 | 77,309 | |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 30.63 | 77,309 | 2,367,975 | 154,618 | |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 30.63 | 77,309 | 2,367,975 | 231,927 | |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 30.63 | 3,264 | 99,976 | 0 | |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 433 | 0 | 143,900 | 144.3 K to 143.9 K (-0.30 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 564 | 0 | 144,333 | 144.9 K to 144.3 K (-0.39 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 578.34 | 100 | 57,834 | 307,749 | 307.8 K to 307.7 K (-0.03 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 577.37 | 683 | 394,344 | 307,849 | 308.5 K to 307.8 K (-0.22 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 576.47 | 206 | 118,753 | 308,532 | 308.7 K to 308.5 K (-0.07 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 575.34 | 2,606 | 1,499,336 | 308,738 | 311.3 K to 308.7 K (-0.84 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 574.69 | 2,622 | 1,506,837 | 311,344 | 314 K to 311.3 K (-0.84 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 573.55 | 2,610 | 1,496,966 | 313,966 | 316.6 K to 314 K (-0.82 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 572.69 | 1,356 | 776,568 | 316,576 | 317.9 K to 316.6 K (-0.43 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 571.32 | 2,877 | 1,643,688 | 317,932 | 320.8 K to 317.9 K (-0.90 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 570.60 | 2,049 | 1,169,159 | 320,809 | 322.9 K to 320.8 K (-0.63 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 569.40 | 3,232 | 1,840,301 | 322,858 | 326.1 K to 322.9 K (-0.99 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 568.43 | 11,447 | 6,506,818 | 326,090 | 337.5 K to 326.1 K (-3.39 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 567.51 | 9,138 | 5,185,906 | 337,537 | 346.7 K to 337.5 K (-2.64 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 566.42 | 14,548 | 8,240,278 | 346,675 | 361.2 K to 346.7 K (-4.03 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 565.47 | 12,996 | 7,348,848 | 361,223 | 374.2 K to 361.2 K (-3.47 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 564.62 | 13,268 | 7,491,378 | 374,219 | 387.5 K to 374.2 K (-3.42 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 563.53 | 11,551 | 6,509,335 | 387,487 | 399 K to 387.5 K (-2.89 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 562.48 | 8,359 | 4,701,770 | 399,038 | 407.4 K to 399 K (-2.05 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 561.40 | 10,418 | 5,848,665 | 407,397 | 417.8 K to 407.4 K (-2.49 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 560.45 | 12,456 | 6,980,965 | 417,815 | 430.3 K to 417.8 K (-2.89 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 559.51 | 8,826 | 4,938,235 | 430,271 | 439.1 K to 430.3 K (-2.01 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 558.36 | 11,168 | 6,235,764 | 439,097 | 450.3 K to 439.1 K (-2.48 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 557.51 | 5,910 | 3,294,884 | 450,265 | 456.2 K to 450.3 K (-1.30 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 556.79 | 1,168 | 650,331 | 456,175 | 457.3 K to 456.2 K (-0.26 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 570.97 | 39,720 | 22,678,928 | 457,343 | 497.1 K to 457.3 K (-7.99 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 30.63 | 77,309 | 2,367,975 | 497,063 | 419.8 K to 497.1 K (+18.42 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 570.97 | 39,974 | 22,823,955 | 419,754 | 459.7 K to 419.8 K (-8.70 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 30.63 | 77,309 | 2,367,975 | 459,728 | 382.4 K to 459.7 K (+20.22 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 570.97 | 39,974 | 22,823,955 | 382,419 | 422.4 K to 382.4 K (-9.46 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 30.63 | 77,309 | 2,367,975 | 422,393 | 345.1 K to 422.4 K (+22.40 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 570.97 | 39,974 | 22,823,955 | 345,084 | 385.1 K to 345.1 K (-10.38 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 30.63 | 77,309 | 2,367,975 | 385,058 | 307.7 K to 385.1 K (+25.12 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 30.63 | 3,264 | 99,976 | 307,749 | 304.5 K to 307.7 K (+1.07 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 30.63 | 187,500 | 5,743,125 | 0 | |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 30.63 | 125,000 | 3,828,750 | 187,500 | |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 577.27 | 638 | 368,298 | 474,499 | 475.1 K to 474.5 K (-0.13 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 576.51 | 1,728 | 996,209 | 475,137 | 476.9 K to 475.1 K (-0.36 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 575.48 | 2,196 | 1,263,754 | 476,865 | 479.1 K to 476.9 K (-0.46 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 574.59 | 4,390 | 2,522,450 | 479,061 | 483.5 K to 479.1 K (-0.91 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 573.27 | 10,014 | 5,740,726 | 483,451 | 493.5 K to 483.5 K (-2.03 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 572.47 | 19,984 | 11,440,240 | 493,465 | 513.4 K to 493.5 K (-3.89 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 571.49 | 15,542 | 8,882,098 | 513,449 | 529 K to 513.4 K (-2.94 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 570.49 | 20,267 | 11,562,121 | 528,991 | 549.3 K to 529 K (-3.69 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 569.52 | 19,982 | 11,380,149 | 549,258 | 569.2 K to 549.3 K (-3.51 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 568.58 | 18,021 | 10,246,380 | 569,240 | 587.3 K to 569.2 K (-3.07 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 567.57 | 9,359 | 5,311,888 | 587,261 | 596.6 K to 587.3 K (-1.57 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 566.51 | 5,810 | 3,291,423 | 596,620 | 602.4 K to 596.6 K (-0.96 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 565.67 | 3,032 | 1,715,111 | 602,430 | 605.5 K to 602.4 K (-0.50 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 564.41 | 779 | 439,675 | 605,462 | 606.2 K to 605.5 K (-0.13 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 563.51 | 2,549 | 1,436,387 | 606,241 | 608.8 K to 606.2 K (-0.42 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 562.75 | 1,394 | 784,474 | 608,790 | 610.2 K to 608.8 K (-0.23 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 561.24 | 3,994 | 2,241,593 | 610,184 | 614.2 K to 610.2 K (-0.65 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 560.68 | 3,391 | 1,901,266 | 614,178 | 617.6 K to 614.2 K (-0.55 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 559.52 | 1,361 | 761,507 | 617,569 | 618.9 K to 617.6 K (-0.22 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 558.35 | 4,162 | 2,323,853 | 618,930 | 623.1 K to 618.9 K (-0.67 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 557.51 | 2,329 | 1,298,441 | 623,092 | 625.4 K to 623.1 K (-0.37 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 571.43 | 96,947 | 55,398,424 | 625,421 | 722.4 K to 625.4 K (-13.42 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 30.63 | 187,500 | 5,743,125 | 722,368 | 534.9 K to 722.4 K (+35.06 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 571.43 | 64,631 | 36,932,092 | 534,868 | 599.5 K to 534.9 K (-10.78 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 30.63 | 125,000 | 3,828,750 | 599,499 | 474.5 K to 599.5 K (+26.34 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 33.42 | 5,000 | 167,100 | 7,500 | |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 575.00 | 300 | 172,500 | 8,700 | 9 K to 8.7 K (-3.33 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 575.00 | 300 | 172,500 | 3,400 | 3.7 K to 3.4 K (-8.11 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 575.00 | 250 | 143,750 | 2,150 | 2.4 K to 2.2 K (-10.42 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 580.00 | 5,000 | 2,900,000 | 115,415 | 120.4 K to 115.4 K (-4.15 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 33.42 | 5,000 | 167,100 | 120,415 | 115.4 K to 120.4 K (+4.33 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 30.63 | 187,500 | 5,743,125 | 0 | |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 30.63 | 125,000 | 3,828,750 | 187,500 | |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 577.27 | 638 | 368,298 | 474,499 | 475.1 K to 474.5 K (-0.13 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 576.51 | 1,728 | 996,209 | 475,137 | 476.9 K to 475.1 K (-0.36 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 575.48 | 2,196 | 1,263,754 | 476,865 | 479.1 K to 476.9 K (-0.46 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 574.59 | 4,390 | 2,522,450 | 479,061 | 483.5 K to 479.1 K (-0.91 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 573.27 | 10,014 | 5,740,726 | 483,451 | 493.5 K to 483.5 K (-2.03 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 572.47 | 19,984 | 11,440,240 | 493,465 | 513.4 K to 493.5 K (-3.89 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 571.49 | 15,542 | 8,882,098 | 513,449 | 529 K to 513.4 K (-2.94 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 570.49 | 20,267 | 11,562,121 | 528,991 | 549.3 K to 529 K (-3.69 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 569.52 | 19,982 | 11,380,149 | 549,258 | 569.2 K to 549.3 K (-3.51 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 568.58 | 18,021 | 10,246,380 | 569,240 | 587.3 K to 569.2 K (-3.07 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 567.57 | 9,359 | 5,311,888 | 587,261 | 596.6 K to 587.3 K (-1.57 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 566.51 | 5,810 | 3,291,423 | 596,620 | 602.4 K to 596.6 K (-0.96 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 565.67 | 3,032 | 1,715,111 | 602,430 | 605.5 K to 602.4 K (-0.50 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 564.41 | 779 | 439,675 | 605,462 | 606.2 K to 605.5 K (-0.13 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 563.51 | 2,549 | 1,436,387 | 606,241 | 608.8 K to 606.2 K (-0.42 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 562.75 | 1,394 | 784,474 | 608,790 | 610.2 K to 608.8 K (-0.23 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 561.24 | 3,994 | 2,241,593 | 610,184 | 614.2 K to 610.2 K (-0.65 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 560.68 | 3,391 | 1,901,266 | 614,178 | 617.6 K to 614.2 K (-0.55 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 559.52 | 1,361 | 761,507 | 617,569 | 618.9 K to 617.6 K (-0.22 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 558.35 | 4,162 | 2,323,853 | 618,930 | 623.1 K to 618.9 K (-0.67 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 557.51 | 2,329 | 1,298,441 | 623,092 | 625.4 K to 623.1 K (-0.37 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 571.43 | 96,947 | 55,398,424 | 625,421 | 722.4 K to 625.4 K (-13.42 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 30.63 | 187,500 | 5,743,125 | 722,368 | 534.9 K to 722.4 K (+35.06 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 571.43 | 64,631 | 36,932,092 | 534,868 | 599.5 K to 534.9 K (-10.78 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 30.63 | 125,000 | 3,828,750 | 599,499 | 474.5 K to 599.5 K (+26.34 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 33.42 | 5,000 | 167,100 | 7,500 | |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 575.00 | 300 | 172,500 | 8,700 | 9 K to 8.7 K (-3.33 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 575.00 | 300 | 172,500 | 3,400 | 3.7 K to 3.4 K (-8.11 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 575.00 | 250 | 143,750 | 2,150 | 2.4 K to 2.2 K (-10.42 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 580.00 | 5,000 | 2,900,000 | 115,415 | 120.4 K to 115.4 K (-4.15 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 33.42 | 5,000 | 167,100 | 120,415 | 115.4 K to 120.4 K (+4.33 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | M | 52.03 | 52,500 | 2,731,575 | 0 | |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | M | 52.03 | 33,079 | 1,721,100 | 52,500 | |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 569.42 | 700 | 398,594 | 28,251 | 29 K to 28.3 K (-2.42 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 568.57 | 3,040 | 1,728,453 | 28,951 | 32 K to 29 K (-9.50 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 567.35 | 3,753 | 2,129,265 | 31,991 | 35.7 K to 32 K (-10.50 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 566.47 | 7,297 | 4,133,532 | 35,744 | 43 K to 35.7 K (-16.95 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 565.49 | 5,984 | 3,383,892 | 43,041 | 49 K to 43 K (-12.21 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 564.54 | 3,000 | 1,693,620 | 49,025 | 52 K to 49 K (-5.77 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 563.58 | 2,195 | 1,237,058 | 52,025 | 54.2 K to 52 K (-4.05 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 562.45 | 2,077 | 1,168,209 | 54,220 | 56.3 K to 54.2 K (-3.69 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 561.55 | 4,988 | 2,801,011 | 56,297 | 61.3 K to 56.3 K (-8.14 %) |